Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Wockhardt USA logo — Stay Well. Do More. Love Life.

Wockhardt USA

Stay Well. Do More. Love Life.

Founded 2004 United States United States 112 employees Debt Financing Total: $20.00M Biotechnology, Life Sciences +1

General Information

Company Name Wockhardt USA
Founded Year 2004
Location United States United States
Employees 112
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Wockhardt USA. To contact Wockhardt USA, visit wockhardtusa.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Wockhardt USA compare?

A PDF of Wockhardt USA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Wockhardt USA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Wockhardt USA

Wockhardt USA is a subsidiary of Wockhardt Limited, established in 2004, focused on the biotechnology and pharmaceutical industries in the United States. Over the years, it has rapidly expanded its portfolio, now representing more than 20% of Wockhardt Ltd’s global business, with over 220 NDCs spanning more than 75 different product families. With more than 14 years of experience in the US market, Wockhardt USA has received over 110 ANDA approvals to date, demonstrating its commitment to product quality and compliance. The acquisition of Morton Grove Pharmaceuticals in October 2007 further strengthened Wockhardt's presence in the US, expanding its product line to include oral liquid and topical pharmaceuticals. Morton Grove has been a key player since 1995, known for its state-of-the-art 125,000 square foot facility, showcasing Wockhardt's strategic moves to diversify its offerings in the market. Wockhardt USA's trajectory signifies its potential for growth and innovation within the pharmaceutical sector, presenting an attractive opportunity for venture capital investment in a company with a strong track record and a focus on delivering high-quality generic oral solids, liquids, topicals, and injectables to the US market.

Business keywords: pharmaceuticals, generic drugs, FDA approved, oral solids, liquids, injectables, product portfolio, acquisitions, manufacturing facilities, expansion, ANDA approvals, Morton Grove Pharmaceuticals, Wockhardt USA, global business

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing £20.00M 1
NatWest Bank
06 Jun 2024

Wockhardt USA Alternatives & Competitors

View All Alternatives
Wockhardt USA vs
Accord Healthcare US
Accord Healthcare US United States

Accord Healthcare is a leading provider of generic and specialty pharmaceuticals.

31 employees
Biotechnology, Pharmaceutical
Wockhardt USA vs
Oxford Pharmaceuticals, LLC
Oxford Pharmaceuticals, LLC United States

Oxford’s mission is to provide affordable, high quality generic drug products to improve the lives o...

41 employees
Biotechnology, Life Sciences
Compare Wockhardt USA vs Oxford Pharmaceuticals, LLC
Wockhardt USA vs
CASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. United States

Bringing life-changing therapeutics to China and the world.

Post-IPO Equity
44 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Wockhardt USA

Stay Well. Do More. Love Life.
Wockhardt USA was founded in 2004.
Wockhardt USA is headquartered in United States.
Wockhardt USA operates in Biotechnology, Life Sciences and Pharmaceutical. Its work centres on pharmaceuticals, generic drugs, FDA approved and oral solids.
Wockhardt USA has approximately 112 employees.
Wockhardt USA has completed 1 funding round, raising a total of $20.00M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Wockhardt USA include Accord Healthcare US, Oxford Pharmaceuticals, LLC, CASI Pharmaceuticals, Inc., Pfizer CentreOne, AUROBINDO PHARMA LTD. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Wockhardt USA and Accord Healthcare US are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Wockhardt USA, https://bouncewatch.com/company/wockhardt-usa, updated 7 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes